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Background
We tried to identify subgroup of patients with Alzheimer's
disease (AD) benefiting from cholinesterase inhibitors
(ChEI) treatment using standardized low-resolution brain
electromagnetic tomography (sLORETA) [1], which
allows to study cortical EEG sources in 6239 cortical grey
matter voxels.
Materials and methods
Resting EEG was recorded in 20 mild to moderate AD
patients (mean age= 75.04 years; 13 women and 7 men;
MMSE 15-24) before and after 6 months and 2 years on
ChEI (donepezil, rivastigmine, galantamine) treatment.
Based on changes of MMSE scores after 2 years follow-up,
11 patients were classified as Non-responders (decrease of
MMSE > 2) and 9 patients as Responders (decrease of
MMSE < 2). The localization of the differences in activity
between two groups (at baseline) and within groups
(baseline vs. 6 months) was assessed by voxel-by-voxel t-
tests of the sLORETA images of the log-transformed com-
puted current density power in seven frequency bands.
Results
At baseline, Non-responders had significantly greater cur-
rent densities in delta and alpha frequency band, which
sLORETA localized in frontal (BA 6,8,9,32; alpha) and
parieto-occipital (BA 7,17,39,40; delta) areas. After 6
months of ChEI treatment only Responders showed an
increase of beta current densities, mainly in left frontal
and temporal cortex.
Conclusions
Our results suggest that there is a subgroup of AD patients
(probably with more pronounced central cholinergic defi-
ciency syndrome) with better response to ChEI treatment,
which can be identified by means of new quantitative EEG
technique (sLORETA).
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